Table of Contents
1 Study Coverage
1.1 Human Alpha1-Proteinase Inhibitor Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Type
1.4.2 0.5g
1.4.3 1g
1.5 Market by Application
1.5.1 Global Human Alpha1-Proteinase Inhibitor Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Alpha1-Proteinase Inhibitor Market Size
2.1.1 Global Human Alpha1-Proteinase Inhibitor Revenue 2014-2025
2.1.2 Global Human Alpha1-Proteinase Inhibitor Sales 2014-2025
2.2 Human Alpha1-Proteinase Inhibitor Growth Rate by Regions
2.2.1 Global Human Alpha1-Proteinase Inhibitor Sales by Regions
2.2.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Human Alpha1-Proteinase Inhibitor Sales by Manufacturers
3.1.1 Human Alpha1-Proteinase Inhibitor Sales by Manufacturers
3.1.2 Human Alpha1-Proteinase Inhibitor Sales Market Share by Manufacturers
3.2 Human Alpha1-Proteinase Inhibitor Revenue by Manufacturers
3.2.1 Human Alpha1-Proteinase Inhibitor Revenue by Manufacturers (2014-2019)
3.2.2 Human Alpha1-Proteinase Inhibitor Revenue Share by Manufacturers (2014-2019)
3.3 Human Alpha1-Proteinase Inhibitor Price by Manufacturers
3.4 Human Alpha1-Proteinase Inhibitor Manufacturing Base Distribution, Product Types
3.4.1 Human Alpha1-Proteinase Inhibitor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Alpha1-Proteinase Inhibitor Product Type
3.4.3 Date of International Manufacturers Enter into Human Alpha1-Proteinase Inhibitor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Human Alpha1-Proteinase Inhibitor Sales by Type
4.2 Global Human Alpha1-Proteinase Inhibitor Revenue by Type
4.3 Human Alpha1-Proteinase Inhibitor Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Human Alpha1-Proteinase Inhibitor Breakdown Data by Application
6 North America
6.1 North America Human Alpha1-Proteinase Inhibitor by Country
6.1.1 North America Human Alpha1-Proteinase Inhibitor Sales by Country
6.1.2 North America Human Alpha1-Proteinase Inhibitor Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Human Alpha1-Proteinase Inhibitor by Type
6.3 North America Human Alpha1-Proteinase Inhibitor by Application
7 Europe
7.1 Europe Human Alpha1-Proteinase Inhibitor by Country
7.1.1 Europe Human Alpha1-Proteinase Inhibitor Sales by Country
7.1.2 Europe Human Alpha1-Proteinase Inhibitor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Alpha1-Proteinase Inhibitor by Type
7.3 Europe Human Alpha1-Proteinase Inhibitor by Application
8 Asia Pacific
8.1 Asia Pacific Human Alpha1-Proteinase Inhibitor by Region
8.1.1 Asia Pacific Human Alpha1-Proteinase Inhibitor Sales by Region
8.1.2 Asia Pacific Human Alpha1-Proteinase Inhibitor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Human Alpha1-Proteinase Inhibitor by Type
8.3 Asia Pacific Human Alpha1-Proteinase Inhibitor by Application
9 Central & South America
9.1 Central & South America Human Alpha1-Proteinase Inhibitor by Country
9.1.1 Central & South America Human Alpha1-Proteinase Inhibitor Sales by Country
9.1.2 Central & South America Human Alpha1-Proteinase Inhibitor Revenue by Country
9.1.3 Brazil
9.2 Central & South America Human Alpha1-Proteinase Inhibitor by Type
9.3 Central & South America Human Alpha1-Proteinase Inhibitor by Application
10 Middle East and Africa
10.1 Middle East and Africa Human Alpha1-Proteinase Inhibitor by Country
10.1.1 Middle East and Africa Human Alpha1-Proteinase Inhibitor Sales by Country
10.1.2 Middle East and Africa Human Alpha1-Proteinase Inhibitor Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Human Alpha1-Proteinase Inhibitor by Type
10.3 Middle East and Africa Human Alpha1-Proteinase Inhibitor by Application
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Company Business Overview
11.1.3 Baxter Human Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Baxter Human Alpha1-Proteinase Inhibitor Products Offered
11.1.5 Baxter Recent Development
11.2 Kamada
11.2.1 Kamada Company Details
11.2.2 Company Business Overview
11.2.3 Kamada Human Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Kamada Human Alpha1-Proteinase Inhibitor Products Offered
11.2.5 Kamada Recent Development
11.3 Talecris Biotherapeutics
11.3.1 Talecris Biotherapeutics Company Details
11.3.2 Company Business Overview
11.3.3 Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Talecris Biotherapeutics Human Alpha1-Proteinase Inhibitor Products Offered
11.3.5 Talecris Biotherapeutics Recent Development
11.4 Aventis Behring
11.4.1 Aventis Behring Company Details
11.4.2 Company Business Overview
11.4.3 Aventis Behring Human Alpha1-Proteinase Inhibitor Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Aventis Behring Human Alpha1-Proteinase Inhibitor Products Offered
11.4.5 Aventis Behring Recent Development
12 Future Forecast
12.1 Human Alpha1-Proteinase Inhibitor Market Forecast by Regions
12.1.1 Global Human Alpha1-Proteinase Inhibitor Sales Forecast by Regions 2019-2025
12.1.2 Global Human Alpha1-Proteinase Inhibitor Revenue Forecast by Regions 2019-2025
12.2 Human Alpha1-Proteinase Inhibitor Market Forecast by Type
12.2.1 Global Human Alpha1-Proteinase Inhibitor Sales Forecast by Type 2019-2025
12.2.2 Global Human Alpha1-Proteinase Inhibitor Revenue Forecast by Type 2019-2025
12.3 Human Alpha1-Proteinase Inhibitor Market Forecast by Application
12.4 North America Human Alpha1-Proteinase Inhibitor Forecast
12.5 Europe Human Alpha1-Proteinase Inhibitor Forecast
12.6 Asia Pacific Human Alpha1-Proteinase Inhibitor Forecast
12.7 Central & South America Human Alpha1-Proteinase Inhibitor Forecast
12.8 Middle East and Africa Human Alpha1-Proteinase Inhibitor Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Alpha1-Proteinase Inhibitor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
Baxter、Kamada、Talecris Biotherapeutics、Aventis Behring
【免責事項】
https://www.globalresearch.jp/disclaimer